4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000237
Director sold 10,111 shares at $85.42 ($863,637)
- Director acquired 10,111 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Diaz Allene M. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,111 | $47.11 | $476,329 | 13,922 | D |
| 2026-07-07 | Sale : show line 2 in the form 10b5-1 | −10,111 | $85.42 | $863,637 | 3,811 | D |
| Open-market sales · 10,111 sh · avg $85.42 · $863,637 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-07 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −10,111 | 0 | D |
Loading xslF345X06/edgardoc.xml…